TBPH
Theravance Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · KY
$17.08
+0.00%0
Insider buys (3m)
3
Insider sells (3m)
-$218.2K
Net value (3m)
+4.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | Sawaf Aziz · officer: SVP & CHIEF FINANCIAL OFFICER | F-InKind | 8,112 | $17 |
| Aug 24, 2026 | Miller Aine · officer: SVP, DEV & HEAD OF IRE OFFICE | F-InKind | 6,258 | $17 |
| Aug 24, 2026 | Winningham Rick E · director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 20,034 | $17 |
| Aug 24, 2026 | Grimaud Brett A. · officer: SVP, GEN COUNSEL AND SECRETARY | F-InKind | 7,952 | $17 |
| Aug 24, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | F-InKind | 5,667 | $17 |
| Jun 23, 2026 | Miller Aine · officer: SVP, DEV & HEAD OF IRE OFFICE | A-Award | 18,750 | $0.00 |
| Jun 17, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | Sale | 6,657 | $16 |
| Jun 17, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | Sale | 3,329 | $16 |
| Jun 17, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | Sale | 3,328 | $16 |
| Jun 16, 2026 | GRAY SUSANNAH · director | A-Award | 13,398 | $17 |
| Jun 16, 2026 | O'Connor Donal · director | A-Award | 6,009 | $0.00 |
| Jun 16, 2026 | Smaldone Alsup Laurie · director | A-Award | 6,009 | $0.00 |
| Jun 16, 2026 | O'Connor Donal · director | A-Award | 13,398 | $17 |
| Jun 16, 2026 | MITCHELL DEAN J · director | A-Award | 6,009 | $0.00 |
| Jun 16, 2026 | PAKIANATHAN DEEPIKA · director | A-Award | 13,398 | $17 |
| Jun 16, 2026 | PAKIANATHAN DEEPIKA · director | A-Award | 6,009 | $0.00 |
| Jun 16, 2026 | MITCHELL DEAN J · director | A-Award | 13,398 | $17 |
| Jun 16, 2026 | Smaldone Alsup Laurie · director | A-Award | 13,398 | $17 |
| Jun 16, 2026 | GRAY SUSANNAH · director | A-Award | 6,009 | $0.00 |
| May 22, 2026 | Sawaf Aziz · officer: SVP & CHIEF FINANCIAL OFFICER | F-InKind | 8,670 | $17 |
| May 22, 2026 | Winningham Rick E · director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | 20,038 | $17 |
| May 22, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | F-InKind | 5,678 | $17 |
| May 22, 2026 | Miller Aine · officer: SVP, DEV & HEAD OF IRE OFFICE | F-InKind | 6,827 | $17 |
| May 22, 2026 | Grimaud Brett A. · officer: SVP, GEN COUNSEL AND SECRETARY | F-InKind | 8,829 | $17 |
| Apr 3, 2026 | Sawaf Aziz · officer: SVP & CHIEF FINANCIAL OFFICER | A-Award | 37,500 | $0.00 |
| Apr 3, 2026 | Grimaud Brett A. · officer: SVP, GEN COUNSEL AND SECRETARY | A-Award | 37,500 | $0.00 |
| Apr 3, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | A-Award | 18,750 | $0.00 |
| Apr 3, 2026 | Winningham Rick E · director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 75,000 | $0.00 |
| Mar 18, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | Sale | 15,534 | $14 |
| Mar 18, 2026 | Farnum Rhonda · officer: SVP, COMM & MEDICAL AFFAIRS | Sale | 7,766 | $14 |
Institutional positioning
13F filings over the trailing two quarters
New 76Increased 126Reduced 104Sold out 27
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | Unchanged | 9,511,150 | May 15, 2026 |
| Madison Avenue Partners, LP | Reduced | 9,212,252 | Aug 14, 2026 |
| Weiss Asset Management LP | Unchanged | 7,457,060 | Aug 14, 2026 |
| WEISS ASSET MANAGEMENT LP | Unchanged | 7,457,060 | May 15, 2026 |
| NEWTYN MANAGEMENT, LLC | Increased | 4,841,629 | May 15, 2026 |
| BlackRock, Inc. | Increased | 4,562,487 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 4,296,290 | May 13, 2026 |
| Newtyn Management, LLC | Reduced | 3,434,191 | Aug 14, 2026 |
| IRENIC CAPITAL MANAGEMENT LP | Unchanged | 2,760,948 | May 18, 2026 |
| Irenic Capital Management LP | Unchanged | 2,760,948 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,783,753 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 1,771,493 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 1,328,584 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 1,297,323 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,276,576 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026